(MENAFN) South Korean pharmaceutical group Ildong Holdings Co. has granted Lee Jung-chi to serve an additional term as its chief.
The company declared it accepted the proposal during a regular stakeholders' meeting that was carried out.
During the meeting, Lee stated "I will push forward various activities to enhance the brand value of various companies in our group and devise ways to secure new profits."
The company also confirmed Lee, who co-chaired it since 2016, to have won an extra three-year term, serving as chief until March 2021.
MENAFN2403201800450000ID1096648219
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.